Genetic variations in the HIF1A gene modulate response to adjuvant chemotherapy after surgery in patients with colorectal cancer

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 11, 2014, Pages 4637-4642

  Zhang, Yi ^a   Wang, Peng ^b   Zhou, Xing Chun ^b   Bao, Guo Qiang ^c   Lyu, Zhuo Ming ^c   Liu, Xiao Nan ^d   Wan, Shao Gui ^e   He, Xian Li ^c   Huang, Qi Chao ^b  

^a Cell Engineering Research Centre   (China)

^b State Key Laboratory of Cancer Biology Experimental Teaching Center of Basic Medicine   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^d FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^e HENAN UNIVERSITY   (China)

Author keywords

Adjuvant chemotherapy; Colorectal cancer; HIF1A; Prognosis; Single nucleotide polymorphism

Indexed keywords

HIF1A PROTEIN, HUMAN; HYPOXIA INDUCIBLE FACTOR 1ALPHA;

ADJUVANT CHEMOTHERAPY; ADOLESCENT; ADULT; AGED; COLORECTAL NEOPLASMS; FEMALE; GENETICS; GENOTYPE; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; PROCEDURES; PROGNOSIS; SINGLE NUCLEOTIDE POLYMORPHISM; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; FEMALE; GENOTYPE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; YOUNG ADULT;

EID: 84903743222     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.11.4637     Document Type: Article

References (29)

1. Baba Y, Nosho K, Shima K, et al (2010). HIF1A overexpression is associated with poor prognosis in a cohort of 731 colorectal cancers. Am J Pathol, 176, 2292-301.
2. Doring F, Onur S, Fischer A, et al (2010). A common haplotype and the Pro582Ser polymorphism of the hypoxia-inducibl factor-1alpha (HIF1A) gene in elite endurance athletes. J Appl Physiol, 108, 1497-500.
3. Frank B, Hoffmeister M, Klopp N, et al (2010). Single nucleotide polymorphisms in Wnt signaling and cell death pathway genes and susceptibility to colorectal cancer. Carcinogenesis. 31, 1381-6.
4. Fu SL, Miao J, Ding B, et al (2014). A polymorphism in the 3' untranslated region of hypoxia-inducible factor-1 alpha confers an increased risk of cervical cancer in aChinese population. Neoplasma, 61, 63-9.
5. Hartwich J, Orr WS, Ng CY, et al (2013). HIF-1alpha activation mediates resistance to anti-angiogenic therapy in neuroblastoma xenografts. J Pediatr Surg, 48, 39-46.
6. Havelund BM, Spindler KL, Ploen J, et al (2012). Single nucleotide polymorphisms in the HIF-1alpha gene and chemoradiotherapy of locally advanced rectal cancer. Oncol Lett, 4, 1056-60.
7. Jemal A, Siegel R, Ward E, et al (2009). Cancer statistics, 2009. CA Cancer J Clin, 59, 225-49.
8. Kang MJ, Jung SA, Jung JM, et al (2011). Associations between single nucleotide polymorphisms of MMP2, VEGF, and HIF1A genes and the risk of developing colorectal cancer. Anticancer Res, 31, 575-84.
9. Kuwai T, Kitadai Y, Tanaka S, et al (2004). Single nucleotide polymorphism in the hypoxia-inducible factor-1alpha gene in colorectal carcinoma. Oncol Rep, 12, 1033-7.
10. Lee SJ, Kim JG, Sohn SK, et al (2011). No association of the hypoxia-inducible factor-1alpha gene polymorphisms with survival in patients with colorectal cancer. Med Oncol, 28, 1032-7.
11. Li C, Lu HJ, Na FF, et al (2013). Prognostic role of hypoxic inducible factor expression in non-small cell lung cancer: a meta-analysis. Asian Pac J Cancer Prev, 14, 3607-12.
12. Li P, Cao Q, Shao PF, et al (2012). Genetic polymorphisms in HIF1A are associated with prostate cancer risk in a Chinese population. Asian J Androl, 14, 864-9.
13. Liao HY, Wang GP, Gu LJ, et al (2012). HIF-1alpha siRNA and cisplatin in combination suppress tumor growth in a nude mice model of esophageal squamous cell carcinoma. Asian Pac J Cancer Prev, 13, 473-7.
14. Liu Y, Bernauer AM, Yingling CM, et al (2012). HIF1alpha regulated expression of XPA contributes to cisplatin resistance in lung cancer. Carcinogenesis, 33, 1187-92.
15. Luan Y, Gao C, Miao Y, et al (2013). Clinicopathological and prognostic significance of HIF-1alpha and HIF-2alpha expression in small cell lung cancer. Pathol Res Pract, 209, 184-9.
16. Mancuso A and Sternberg CN (2005). Colorectal cancer and antiangiogenic therapy: what can be expected in clinical practice? Crit Rev Oncol Hematol, 55, 67-81.
17. Marton I, Knezevic F, Ramic S, et al (2012). Immunohistochemical expression and prognostic significance of HIF-1alpha and VEGF-C in neuroendocrine breast cancer. Anticancer Res, 32, 5227-32.
18. O'Donnell JL, Joyce MR, Shannon AM, et al (2006). Oncological implications of hypoxia inducible factor-1alpha (HIF-1alpha) expression. Cancer Treat Rev, 32, 407-16.
19. Pearson JR, Gill CI, and Rowland IR (2009). Diet, fecal water, and colon cancer--development of a biomarker. Nutr Rev, 67, 509-26.
20. Ranasinghe WK, Xiao L, Kovac S, et al (2013). The role of hypoxia-inducible factor 1alpha in determining the properties of castrate-resistant prostate cancers. PLoS One, 8, 54251.
21. Semenza GL (2003). Targeting HIF-1 for cancer therapy. Nat Rev Cancer, 3, 721-32.
22. Szkandera J, Knechtel G, Stotz M, et al (2010). Association of hypoxia-inducible factor 1-alpha gene polymorphisms and colorectal cancer prognosis. Anticancer Res, 30, 2393-7.
23. Wada H, Nagano H, Yamamoto H, et al (2006). Expression pattern of angiogenic factors and prognosis after hepatic resection in hepatocellular carcinoma: importance of angiopoietin-2 and hypoxia-induced factor-1 alpha. Liver Int, 26, 414-23.
24. Wan XB, Fan XJ, Huang PY, et al (2012). Aurora-A activation, correlated with hypoxia-inducible factor-1alpha, promotes radiochemoresistance and predicts poor outcome for nasopharyngeal carcinoma. Cancer Sci, 103, 1586-94.
25. Wu Y, Jin M, Xu H, et al (2010). Clinicopathologic significance of HIF-1alpha, CXCR4, and VEGF expression in colon cancer. Clin Dev Immunol, 2010.
26. Zhang YY, Chen B, and Ding YQ (2012). Metastasis-associated factors facilitating the progression of colorectal cancer. Asian Pac J Cancer Prev, 13, 2437-44.
27. Zhang ZG, Zhang QN, Wang XH, et al (2013). Hypoxia-inducible factor 1 alpha (HIF-1alpha) as a prognostic indicator in patients with gastric tumors: a meta-analysis. Asian Pac J Cancer Prev, 14, 4195-8.
28. Zhong H, De Marzo AM, Laughner E, et al (1999). Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res, 59, 5830-5.
29. Zhou F, He X, Liu H, et al (2012). Functional polymorphisms of circadian positive feedback regulation genes and clinical outcome of Chinese patients with resected colorectal cancer. Cancer, 118, 937-46.